OUR 9TH YEAR OF PROVIDING PROPRIETARY CAPITAL MARKETS INTELLIGENCE ON THE CANNABIS / HEMP / PSYCHEDELIC SECTORS
M&A Transactions
M&A Transaction Chart
Viridian publishes weekly data on M&A transactions in the Cannabis/CBD/Psychedelic industries. This data includes information about the buyer and seller (public/private, state/country location), deal size, deal structure (cash, stock, earn-out), pricing, share information, and deal implied valuation.
Week ended 04/26/2024
Week ended 04/26/2024
This Section is Only Available to Higher Tier Memberships
Please Purchase a Premium or Enterprise membership to see more.
M&A Transactions Commentary
Week ended 04/26/2024
- The Only Closed M&A Deal of the Week:
- On April 22, 2024, Curaleaf (CURA: TSX) announced the closing of its acquisition of Northern Green Canada (“NGC”), an Ontario-based vertically integrated licensed cannabis producer focused primarily on expanding in the international market through its EU-GMP certification.
- The acquisition will give Curaleaf a supply of high-quality quality, non-irradiated, indoor EU-GMP flower
- NCG also provides an entry to the rapidly growing Australian market.
- The transaction value of $16M was paid in Curaleaf stock with additional earnouts payable in 2025 based on 2024 performance.
- Although no financials were disclosed on NGC, Curaleaf stated that the acquisition would be accretive.
Week ended 04/26/2024
This is the MA basic
Additional content is available to Premium and Enterprise users. Please purchase a higher tier membership to see more.
Viridian publishes weekly insights on the M&A landscape in the Cannabis/CBD/Psychedelic industries. These insights typically highlight the most interesting/meaningful M&A transactions for that week, and commentary on market conditions, M&A deal structures, target regions for acquirers, and industry sectors ripe for consolidation.